Stay updated on Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Sign up to get notified when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.

Latest updates to the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page
- Check3 days agoChange DetectedThe page revision indicator was updated from v3.5.4 to v3.5.5, signaling a recent update to the study record on ClinicalTrials.gov. This represents a small, system-level refresh to the page rather than a change to the study data.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a site deployment update. No study content or data appear to have changed.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page’s footer version label was updated from one revision number to the next (v3.5.2 → v3.5.3), reflecting a site/display revision rather than any changes to the clinical trial record.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.5.2 replaces the previous v3.5.0.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Rhabdomyosarcoma as a focus term and included Genetic and Rare Diseases Information Center as a Resources link. Updated page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check90 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. This appears to be a minor site maintenance update with no changes to study details or visible features.SummaryDifference0.1%

Stay in the know with updates to Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.